metabolic · clinical-trial
Retatrutide
Triplo agonista GIP/GLP-1/Glucagon.
Status:clinical-trial
Updated:May 13, 2026
Contributors:2
Half-life
144 h
Routes
SC
Typical dose
2000–12000 mcg
Mechanism of action
Modula 3 receptores incretínicos simultaneamente.
Reported applications
- · weight management
- · metabolic
Frequently asked
What is Retatrutide?
Triplo agonista GIP/GLP-1/Glucagon.
What is the half-life of Retatrutide?
Reference half-life: approximately 144 hours. Individual pharmacokinetics may vary.
Is PX7 prescribing Retatrutide?
No. PX7 is an educational reference and a community knowledge layer. It does not prescribe, sell, or recommend substances.
Explore the cluster
PX7 publishes educational and community-curated references on regenerative and longevity science. Nothing on this page is medical advice, prescription, or a recommendation to obtain or use any substance. Always consult a qualified clinician.